Targeting NK cell CLEC12B enhances cancer immunotherapy

Journal:
Nature Immunology
Published:
DOI:
10.1038/s41590-026-02471-0
Affiliations:
6
Authors:
11
Institutions Authors Share
University of Science and Technology of China (USTC), China
4.166667
0.38
State Key Laboratory of Immune Response and Immunotherapy, China
3.416667
0.31
The First Affiliated Hospital, USTC, China
3.166667
0.29
The First Affiliated Hospital, SYSU, China
0.250000
0.02